Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study

BACKGROUND: Vinorelbine is known to be effective in the treatment of non-small cell lung cancer and breast cancer. However, venous irritation is a common side effect. Although there have been some reports on risk factors for venous irritation in patients receiving vinorelbine, the factors evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Yoshihito, Miyawaki, Kumika, Seki, Reisuke, Watanabe, Kazuhiro, Hirohara, Masayoshi, Shinohara, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166274/
https://www.ncbi.nlm.nih.gov/pubmed/30288295
http://dx.doi.org/10.1186/s40780-018-0122-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166274/
https://www.ncbi.nlm.nih.gov/pubmed/30288295
http://dx.doi.org/10.1186/s40780-018-0122-2

Ejemplares similares